Greenland Mines Ltd. (NASDAQ: GRML) has officially closed the acquisition of the Sarfartoq Nd-Pr Rare Earths Project in southwest Greenland, a move that positions the company as a significant player in the global rare earth supply chain. The transaction, valued at $20 million in cash and $15 million in securities, was completed on September 1, 2026, marking a critical step in Greenland Mines' strategy to diversify rare earth sources outside China.
The Sarfartoq project is notable for its planned annual production of neodymium-praseodymium (NdPr) oxide, which would represent approximately 34% of all NdPr oxide refined outside China at 2025 consumption levels during each of its nine scheduled operating years. This underscores the project's potential to alleviate supply chain bottlenecks that have plagued Western manufacturers reliant on Chinese rare earth exports. An independent Initial Assessment, based solely on the ST1 deposit, estimates a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%, with Indicated and Inferred Mineral Resources supporting these figures.
With the acquisition complete, Greenland Mines is advancing Sarfartoq toward a Pre-Feasibility Study. Planned activities include targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, environmental and social baseline studies, and drone-based magnetic surveys. These efforts are designed to de-risk the project and provide the technical and economic data necessary for a comprehensive feasibility assessment.
A strategic element of the transaction is the involvement of Neo Performance Materials (TSX: NEO), which became a strategic shareholder in Greenland Mines through the deal. Neo retains offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production, which will be processed at its Silmet rare earth separation facility in Estonia. This partnership ensures a ready market for Sarfartoq's output and strengthens the project's integration into Western supply chains, reducing dependence on Chinese processing.
The Sarfartoq project aligns with Greenland Mines' broader vision of a North Atlantic Critical Metals Corridor, linking Greenland's resources with allied downstream jurisdictions and industrial infrastructure. The company operates two divisions: Mining, focused on exploration and development of the Skaergaard Project in southeast Greenland and now Sarfartoq, and Biotech, which includes Klotho's KLTO-202 primary indication for ALS. This multi-asset platform is designed to provide exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities.
The significance of this acquisition extends beyond Greenland Mines. As global demand for rare earth elements, particularly NdPr used in permanent magnets for electric vehicles, wind turbines, and electronics, continues to surge, the need for diversified supply sources becomes critical. Sarfartoq's potential to supply a substantial portion of non-Chinese NdPr oxide is a strategic advantage for Western nations seeking to secure their supply chains and reduce geopolitical risks.
For more information on the press release, visit https://ibn.fm/rTIg0.
